Revolna Therapeutics is developing an innovative RNA platform to deliver transformative treatments. Our initial focus is on cystic fibrosis, with the potential to scale across many other indications.
Transformative Treatments
Revolna Therapeutics is revolutionizing cystic fibrosis care with our innovative Ro-RNA platform, bringing hope and long-lasting treatment solutions to patients. Starting with cystic fibrosis as our focus, we aim to demonstrate proof of principle and then expand into other indications, unlocking the potential of our platform to transform treatments across a wide range of diseases..